BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4870544)

  • 1. Effects of hypothalamic lesions on incidence and growth of mammary tumors in carcinogen-treated rats.
    Clemens JA; Welsch CW; Meites J
    Proc Soc Exp Biol Med; 1968 Mar; 127(3):969-72. PubMed ID: 4870544
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Welsch CW; Clemens JA; Meites J
    J Natl Cancer Inst; 1968 Aug; 41(2):465-71. PubMed ID: 5671287
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of hypothalamic and amygdaloid lesions on development and growth of carcinogen-induced mammary tumors in the female rat.
    Welsch CW; Clemens JA; Meites J
    Cancer Res; 1969 Aug; 29(8):1541-9. PubMed ID: 5807229
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats.
    Heuson JC; Legros N; Heimann R
    Cancer Res; 1972 Feb; 32(2):233-8. PubMed ID: 5058184
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of prolactin or growth hormone on growth of carcinogen-induced mammary tumors of adreno-ovariectomized rats.
    Nagasawa H; Yanai R
    Int J Cancer; 1970 Nov; 6(3):488-95. PubMed ID: 5486607
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction by pituitary isograft of inhibitory effect of large dose of estrogen on incidence of mammary tumors induced by carcinogen in ovariectomized rats.
    Nagasawa H; Yanai R
    Int J Cancer; 1971 Nov; 8(3):463-7. PubMed ID: 5137309
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of human placental lactogen on growth of carcinogen-induced mammary tumors in rats.
    Nagasawa H; Yanai R
    Int J Cancer; 1973 Jan; 11(1):131-7. PubMed ID: 4790832
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a hypothalamic estrogen implant on growth of carcinogen-induced mammary tumors in rats.
    Nagasawa H; Meites J
    Cancer Res; 1970 May; 30(5):1327-9. PubMed ID: 5426935
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased incidence of spontaneous mammary tumors in female rats with induced hypothalamic lesions.
    Welsch CW; Nagasawa H; Meites J
    Cancer Res; 1970 Sep; 30(9):2310-3. PubMed ID: 5529115
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats.
    Cassell EE; Meites J; Welsch CW
    Cancer Res; 1971 Jul; 31(7):1051-3. PubMed ID: 5560385
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolactin and growth hormone levels in the anterior pituitary of rats bearing mammary tumor induced by 7,12-dimethylbenz [a] anthracene.
    Yanai R; Nagasawa H
    Gan; 1968 Dec; 59(6):543-6. PubMed ID: 5721587
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of a norethynodrel-mestranol combination (enovid) on development and growth of carcinogen-induced mammary tumors in female rats.
    Welsch CW; Meites J
    Cancer; 1969 Mar; 23(3):601-7. PubMed ID: 5766502
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between serum prolactin levels and incidence of mammary tumors induced by 7,12-dimethylbenz(alpha)anthracene in the rat.
    Gala RR; Loginsky SJ
    J Natl Cancer Inst; 1973 Aug; 51(2):593-7. PubMed ID: 4765374
    [No Abstract]   [Full Text] [Related]  

  • 14. Relation of prolactin and estrogen to mammary tumorigenesis in the rat.
    Meites J
    J Natl Cancer Inst; 1972 Apr; 48(4):1217-24. PubMed ID: 5023679
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of estrogen and-or pituitary graft on nucleic acid synthesis of carcinogen-induced mammary tumors in rats.
    Nagasawa H; Yanai R
    J Natl Cancer Inst; 1974 Apr; 52(4):1219-22. PubMed ID: 4826589
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of hypothalamic lesions on the induction and growth of mammary cancers in Sprague-Dawley rats receiving 7,12-dimethylbenz(a)anthracene.
    Klaiber MS; Gruenstein M; Meranze DR; Shimkin MB
    Cancer Res; 1969 May; 29(5):999-1001. PubMed ID: 4889111
    [No Abstract]   [Full Text] [Related]  

  • 17. The nature of estrogen and prolactin effect on mammary tumorigenesis.
    Sinha D; Cooper D; Dao TL
    Cancer Res; 1973 Feb; 33(2):411-4. PubMed ID: 4688888
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression by ergocornine and iproniazid of carcinogen-induced mammary tumors in rats; effects on serum and pituitary prolactin levels.
    Nagasawa H; Meites J
    Proc Soc Exp Biol Med; 1970 Nov; 135(2):469-72. PubMed ID: 5480010
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of pituitary homografts on host pituitary prolactin and hypothalamic PIF levels.
    Welsch CW; Negro-Vilar A; Meites J
    Neuroendocrinology; 1968; 3(4):238-45. PubMed ID: 4882739
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogen inhibition of mammary tumor growth in rats; counteraction by prolactin.
    Meites J; Cassell E; Clark J
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1225-7. PubMed ID: 5138448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.